Commercialization Advisory
Helping Your Innovation Navigate the U.S. Market
Strategic commercialization advisory for healthcare companies entering, navigating, or scaling in the U.S. market.
The Reality
FDA Approval Is Not the Finish Line.
Every year, innovative healthcare companies secure regulatory clearance — only to stall before reaching patients. The gap between approval and market adoption is where most companies fail. They burn through millions on sales strategies that don't account for reimbursement, clinical workflow integration, or payer dynamics.
90%
of startups fail in the long run – Failory
$54M+
mean development cost for a novel therapeutic complex medical device — JAMA Network
7–10 yrs
typical timeline to exit for medical devices — AdvaMed
Who We Serve
If You See Yourself Here, We Built This For You.
Four distinct client types, each with a unique set of commercialization challenges.
-
International Health Innovators
Companies outside the U.S. looking to enter the world's largest healthcare market — and avoid costly missteps.
-
MedTech & Device Founders
Post-clearance or pre-submission teams that need a commercialization strategy, not just a regulatory one.
-
Digital Health & AI Companies
SaaS and AI-enabled solutions navigating FDA pathways, payer dynamics, and real-world adoption at scale.
-
Medical VCs & Incubators
VCs and incubators who need portfolio companies evaluated for commercial viability and U.S. market fit.
What We Deliver
Two Things. Done at the Highest Level.
We don't sell a menu of services. We deliver commercialization strategy and hands-on guidance — and everything we produce is built to make you credible, clear, and ready for the U.S. market.
-
ABIG Ready™ Diagnostic
Fixed Engagement
A comprehensive assessment of your commercialization readiness. We take a critical look at everything moving across your product lifecycle so nothing falls through the cracks.✓ Comprehensive commercialization assessment
✓ Regulatory & reimbursement gap analysis
✓ Market & competitive positioning
✓ Clinical workflow & adoption review
✓ Actionable roadmap with clear priorities
✓ Stakeholder-ready executive summary
-
Strategic Advisory
Hourly / Retainer / Project-Based
Ongoing senior partner guidance across the full commercialization journey — from evidence development to stakeholder engagement to commercial traction.
✓ Senior partner advisory hours
✓ Ongoing strategy & GTM coaching
✓ Reimbursement & payer strategy
✓ Clinical workflow integration planning
✓ Investor readiness & pitch support
✓ Market research & competitive analysis
Our Unique Perspective
Clinician-Led. Policy-Backed. Execution-Ready.
COMMERCIALIZATION GAP ANALYSIS & STRATEGY
Led by Dr. Steve Farmer
Former CMS Chief Strategy Officer for Coverage
We assess where you are, where you need to go, and what's standing in the way — regulatory, reimbursement, clinical workflow, payer landscape. We map every obstacle and build the strategy to overcome them.
CLINICAL GO-TO-MARKET STRATEGY
Led by Dr. Adam Brown
Founder & Principal, ABIG
Hands-on clinical GTM guidance from a practicing ER physician and Key Opinion Leader (KOL) who understands how healthcare decisions are made from the bedside, the boardroom, and the budget line.
